Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Less extensive biopsy method helps diagnose cancer progression of large breast tumors

23.08.2005


New breast cancer research shows for the first time that even women with large breast tumors can benefit from a less invasive biopsy method that has been reserved until now for women with small breast cancers.



Lymphatic mapping and sentinel node biopsy, when used to determine how far the cancer has progressed into the lymph nodes, can help some patients avoid the pain and discomfort of full armpit node removal, which often causes swelling, numbness and infection.

The surgical technique hasn’t been used until now in women with large breast tumors because of a lack of data proving its reliability.


But the new study from the University of North Carolina at Chapel Hill School of Medicine may provide that research evidence.

The findings, published in the September issue of the American Journal of Surgery, show that sentinel node biopsy, when performed before chemotherapy is given to shrink the tumor, is very reliable, the UNC researchers said.

The study suggests that sentinel node biopsy is an option that might benefit all women with breast cancers, said Dr. David W. Ollila, the study’s lead author. Ollila is an associate professor of surgery at UNC and a member of the UNC Lineberger Comprehensive Cancer Center.

"I think any woman diagnosed with breast cancer should ask her physician what role this technique might play in her overall treatment," Ollila said.

Lymphatic mapping and sentinel lymphadenectomy before chemotherapy is the standard of care for patients with small breast cancers. But its use in large breast cancers has been controversial because of lack of reliability, he said.

"Our study indicates that women with large breast cancers can derive a benefit from the sentinel node technology just like women with small breast cancers," Ollila added.

In sentinel node biopsy, a surgeon injects the area near the tumor with a blue dye, which follows the path that tumor cells most likely would take from the tumor to the lymph nodes. The surgeon removes only the nodes that initially absorb the dye. These are thought to be the "sentinel" nodes, the nodes to which cancer cells are most likely to travel. If the biopsy finds no cancer in the sentinel nodes, then no further nodes are removed.

Subjects in the study were 21 breast cancer patients with tumors large enough in relation to the size of the breast that the breast could not be preserved.

Such patients typically receive neoadjuvant chemotherapy to shrink the tumor before surgery, to decrease chances of recurrence and, for a small number of women, to make it feasible to have a lumpectomy rather than a mastectomy.

Before neoadjuvant chemotherapy, the researchers performed sentinel node biopsy, modifying the technique slightly for larger cancers by using a larger volume of dye and more injections.

If the procedure showed disease in the sentinel node or if the tumor was larger than five centimeters, all the axillary nodes were removed, and the patient received chemotherapy and surgery. If the biopsy showed tumor-free sentinel nodes, and the tumor was less than five centimeters in diameter, no further lymph nodes were removed and the patient received chemotherapy and tumor removal.

In an average of 36 months of post-treatment follow-up, none of the patients showed progression of cancer in the lymph nodes. The sentinel node biopsy accurately predicted node involvement, with a false negative rate of 0 percent, Ollila said.

Some surgeons advocate performing sentinel node biopsy in women with large tumors only after chemotherapy to discover how much of the tumor is left behind. However, these results show that performing the procedure before treatment provides a more accurate picture of lymph node involvement, Ollila said.

"If sentinel node biopsy is done after chemotherapy, the false negative rate skyrockets," he said.

Published studies show false negative rates as high as 33 percent when the procedure is performed only after chemotherapy. False negatives may result, for example, when chemotherapy kills cancer cells in the sentinel node but not in other nodes.

"We’re looking at a way in which the patient has definitive breast cancer and nodal staging before she ever undergoes chemotherapy, so we know exactly where she starts," Ollila said. "Performing this procedure before neoadjuvant chemotherapy makes it easier for the medical oncologist and the radiation oncologist to know exactly what they need to do."

Other authors of the study are UNC Lineberger and medical school faculty members Drs. Carolyn Sartor, assistant professor of radiation oncology; Lisa A. Carey, assistant professor of medicine; and Nancy Klauber-DeMore, assistant professor of surgery. Dr. Heather B. Neuman, a resident in the department of surgery, also is co-author.

Leslie H. Lang | EurekAlert!
Further information:
http://www.med.unc.edu

More articles from Health and Medicine:

nachricht Researchers release the brakes on the immune system
18.10.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn

nachricht Norovirus evades immune system by hiding out in rare gut cells
12.10.2017 | University of Pennsylvania School of Medicine

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Neutron star merger directly observed for the first time

University of Maryland researchers contribute to historic detection of gravitational waves and light created by event

On August 17, 2017, at 12:41:04 UTC, scientists made the first direct observation of a merger between two neutron stars--the dense, collapsed cores that remain...

Im Focus: Breaking: the first light from two neutron stars merging

Seven new papers describe the first-ever detection of light from a gravitational wave source. The event, caused by two neutron stars colliding and merging together, was dubbed GW170817 because it sent ripples through space-time that reached Earth on 2017 August 17. Around the world, hundreds of excited astronomers mobilized quickly and were able to observe the event using numerous telescopes, providing a wealth of new data.

Previous detections of gravitational waves have all involved the merger of two black holes, a feat that won the 2017 Nobel Prize in Physics earlier this month....

Im Focus: Smart sensors for efficient processes

Material defects in end products can quickly result in failures in many areas of industry, and have a massive impact on the safe use of their products. This is why, in the field of quality assurance, intelligent, nondestructive sensor systems play a key role. They allow testing components and parts in a rapid and cost-efficient manner without destroying the actual product or changing its surface. Experts from the Fraunhofer IZFP in Saarbrücken will be presenting two exhibits at the Blechexpo in Stuttgart from 7–10 November 2017 that allow fast, reliable, and automated characterization of materials and detection of defects (Hall 5, Booth 5306).

When quality testing uses time-consuming destructive test methods, it can result in enormous costs due to damaging or destroying the products. And given that...

Im Focus: Cold molecules on collision course

Using a new cooling technique MPQ scientists succeed at observing collisions in a dense beam of cold and slow dipolar molecules.

How do chemical reactions proceed at extremely low temperatures? The answer requires the investigation of molecular samples that are cold, dense, and slow at...

Im Focus: Shrinking the proton again!

Scientists from the Max Planck Institute of Quantum Optics, using high precision laser spectroscopy of atomic hydrogen, confirm the surprisingly small value of the proton radius determined from muonic hydrogen.

It was one of the breakthroughs of the year 2010: Laser spectroscopy of muonic hydrogen resulted in a value for the proton charge radius that was significantly...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ASEAN Member States discuss the future role of renewable energy

17.10.2017 | Event News

World Health Summit 2017: International experts set the course for the future of Global Health

10.10.2017 | Event News

Climate Engineering Conference 2017 Opens in Berlin

10.10.2017 | Event News

 
Latest News

Terahertz spectroscopy goes nano

20.10.2017 | Information Technology

Strange but true: Turning a material upside down can sometimes make it softer

20.10.2017 | Materials Sciences

NRL clarifies valley polarization for electronic and optoelectronic technologies

20.10.2017 | Interdisciplinary Research

VideoLinks
B2B-VideoLinks
More VideoLinks >>>